We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Image Cytometry Measures Mononuclear Cell Concentration

By LabMedica International staff writers
Posted on 12 Feb 2013
A rapid fluorescence-based image cytometry system has been utilized for brightfield and fluorescence imaging analysis of cellular characteristics. More...


The viability and concentration of isolated peripheral blood mononuclear cells (PBMCs) are traditionally measured by manual counting with trypan blue (TB) using a hemacytometer, but red blood cell (RBC) contamination can be an issue.

Scientists at the Nexcelom Bioscience Laboratories, (Lawrence, MA, USA) compared their Cellometer Vision instrument with both manual counting and automatic method for accurately measuring the concentration of PBMCs in prepared blood samples. Fifteen freshly isolated samples were stained with acridine orange and propidium iodide (AO/PI) to identify RBC contamination. The five different methods were manual counting of TB-stained PBMCs in hemacytometer; manual counting of PBMCs in brightfield images; manual counting of acetic acid lysing of RBCs with TB-stained PBMCs; automated counting of acetic acid lysing of RBCs with PI-stained PBMCs; and AO/PI dual staining method.

Each of the 15 samples measured was categorized into low, medium, or high RBC contamination. Five samples showed less than 10% of RBC contamination, six samples showed 10% to 40% of RBC contamination, and four samples showed RBC contamination greater than 40%. The total particles counted in brightfield increased due to the addition of RBCs, while AO/PI staining showed consistent measurement of PBMCs, which again demonstrated the robustness of the method despite RBC contamination. Although inherent RBC contaminants may have existed in the sample, the purpose was to observe the increasing difference between fluorescently stained nucleated cells and total brightfield cell count including RBCs.

The authors concluded that fluorescence-based image cytometry can be utilized to eliminate the RBC-induced error in patient samples, which can improve accuracy and efficiency of PBMC measurement. Cellometer image cytometry has also demonstrated fluorescence-based cell population analysis such as apoptosis detection, cell cycle, as well as surface marker labeling. The system can be used to perform immunophenotyping of collected PBMCs, and can quickly characterize incoming patient samples, further simplifying PBMC characterization protocol. The study was published in the February 2013 issue of the Journal of Immunological Methods.

Related Links:
Nexcelom Bioscience


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.